PDF herunterladen
CC BY-NC-ND 4.0 · Endosc Int Open 2024; 12(11): E1425-E1433
DOI: 10.1055/a-2462-0466
Original article

Areas of improvement for colorectal cancer screening: Results of a screening initiative for 10,000 health care employees in Austria

Julian Prosenz 
1   GI Endoscopy Quality Matters working group (GIEQM), Karl Landsteiner University of Health Sciences, Krems, Austria (Ringgold ID: RIN467773)
2   Internal Medicine 2 Gastroenterology & Hepatology, University Hospital St Pölten, St Polten, Austria (Ringgold ID: RIN31420)
3   Medical Science Research Program, Paracelsus Medical University Salzburg, Salzburg, Austria (Ringgold ID: RIN31507)
4   Quality Assurance Working Group, Austrian Society for Gastroenterology and Hepatology, Wien, Austria (Ringgold ID: RIN606838)
,
Zoe Anne Österreicher
5   Division of Gastroenterology & Hepatology, Karl Landsteiner University of Health Sciences, Krems an der Donau, Austria (Ringgold ID: RIN467773)
2   Internal Medicine 2 Gastroenterology & Hepatology, University Hospital St Pölten, St Polten, Austria (Ringgold ID: RIN31420)
,
Florian Koutny
5   Division of Gastroenterology & Hepatology, Karl Landsteiner University of Health Sciences, Krems an der Donau, Austria (Ringgold ID: RIN467773)
2   Internal Medicine 2 Gastroenterology & Hepatology, University Hospital St Pölten, St Polten, Austria (Ringgold ID: RIN31420)
3   Medical Science Research Program, Paracelsus Medical University Salzburg, Salzburg, Austria (Ringgold ID: RIN31507)
,
Arno Asaturi
2   Internal Medicine 2 Gastroenterology & Hepatology, University Hospital St Pölten, St Polten, Austria (Ringgold ID: RIN31420)
,
Moira Birkl
5   Division of Gastroenterology & Hepatology, Karl Landsteiner University of Health Sciences, Krems an der Donau, Austria (Ringgold ID: RIN467773)
2   Internal Medicine 2 Gastroenterology & Hepatology, University Hospital St Pölten, St Polten, Austria (Ringgold ID: RIN31420)
,
Rosanna Hanke
5   Division of Gastroenterology & Hepatology, Karl Landsteiner University of Health Sciences, Krems an der Donau, Austria (Ringgold ID: RIN467773)
,
Monika Ferlitsch
6   Gastroenterology and Hepatology, Medical University of Vienna, Vienna, Austria
4   Quality Assurance Working Group, Austrian Society for Gastroenterology and Hepatology, Wien, Austria (Ringgold ID: RIN606838)
,
Andreas Maieron 
1   GI Endoscopy Quality Matters working group (GIEQM), Karl Landsteiner University of Health Sciences, Krems, Austria (Ringgold ID: RIN467773)
2   Internal Medicine 2 Gastroenterology & Hepatology, University Hospital St Pölten, St Polten, Austria (Ringgold ID: RIN31420)
3   Medical Science Research Program, Paracelsus Medical University Salzburg, Salzburg, Austria (Ringgold ID: RIN31507)
4   Quality Assurance Working Group, Austrian Society for Gastroenterology and Hepatology, Wien, Austria (Ringgold ID: RIN606838)
› InstitutsangabenGefördert durch: Karl Landsteiner Privatuniversität für Gesundheitswissenschaften SF_0047
› Weitere Informationen
Auch verfügbar auf
   Lizenzen und Reprints

Abstract

Background and study aims Participation in and quality of colorectal cancer (CRC) screening varies greatly and it is unclear how much of CRC screening guideline quality metrics reach patients. The aims of this prospective observational study were to provide data from everyday practice in Austria.

Patients and methods All employees aged ≥ 50 years were invited and received a stool-based-test (FIT (cut-off 25 mcg Hb/g) and M2PK), which could be dropped off at the workplace. All individuals with positive tests were called and offered a colonoscopy near their workplace/home in ≤ 3 weeks performed by unselected endoscopists. Non-attendees received email and telephone reminders.

Results Of 10,239 eligible employees (2706 males, 7533 females), 2390 (23%) (plus 673 < 50 years) median age 53 (interquartile range 50;56) participated in the stool-based screening (18% males, 25% females). Of 3063 tests, 747 (24%) were positive. The follow-up rate for 616 individuals who accepted or eventually underwent colonoscopy was 84% (n = 517). The adenoma detection rate (ADR) was 20.5% (31% in men, 17% in women) and varied substantially, ranging from 15% in hospitals (excluding the study center) to 18.5% among office-based endoscopists, and up to 36% in the study center. Most European Society of Gastrointestinal Endoscopy-recommended performance indicators were unmet, including the polyp detection rate (PDR), ADR, reporting of polyp characteristics, and bowel preparation adequacy.

Conclusions There is a serious gap between recommended standards and real-world CRC screening colonoscopy quality. Implementation of CRC screening should not only be accompanied by strategies to increase participation rates but focus on implementation of rigorous, mandatory colonoscopy quality assurance programs.

Keywords

Endoscopy Lower GI Tract - Polyps/adenomas/... - CRC screening - Quality and logistical aspects - Quality management - Performance and complications


Publikationsverlauf

Eingereicht: 26. August 2024

Angenommen nach Revision: 12. Oktober 2024

Artikel online veröffentlicht:
28. November 2024

© 2024. The Author(s). This is an open access article published by Thieme under the terms of the Creative Commons Attribution-NonDerivative-NonCommercial-License, permitting copying and reproduction so long as the original work is given appropriate credit. Contents may not be used for commercial purposes, or adapted, remixed, transformed or built upon. (https://creativecommons.org/licenses/by-nc-nd/4.0/).

Georg Thieme Verlag KG
Oswald-Hesse-Straße 50, 70469 Stuttgart, Germany

 

  • References

  • 1 Brenner H, Heisser T, Cardoso R. et al. Reduction in colorectal cancer incidence by screening endoscopy. Nat Rev Gastroenterol Hepatol 2023; 21: 125-133
    CrossrefPubMedSuche in Google Scholar
  • 2 Franklyn J, Lomax J, Labib P. et al. Colorectal cancer outcomes determined by mode of presentation: analysis of population data in England between 2010 and 2014. Tech Coloproctol 2022; 26: 363-372
    CrossrefPubMedSuche in Google Scholar
  • 3 Colorectal Cancer Screening Across Europe. 2018 UEG (United European Gastroenterology). https://ueg.eu/files/779/67d96d458abdef21792e6d8e590244e7.pdf
    PubMed
  • 4 Bretthauer M, Loberg M, Wieszczy P. et al. Effect of colonoscopy screening on risks of colorectal cancer and related death. N Engl J Med 2022; 387: 1547-1556
    CrossrefPubMedSuche in Google Scholar
  • 5 Moss S, Ancelle-Park R, Brenner H. et al. European guidelines for quality assurance in colorectal cancer screening and diagnosis. First Edition--Evaluation and interpretation of screening outcomes. Endoscopy 2012; 44: SE49-SE64
    Thieme ConnectPubMedSuche in Google Scholar
  • 6 Kaminski MF, Robertson DJ, Senore C. et al. Optimizing the quality of colorectal cancer screening worldwide. Gastroenterology 2020; 158: 404-417
    CrossrefPubMedSuche in Google Scholar
  • 7 Cardoso R, Guo F, Heisser T. et al. Utilisation of colorectal cancer screening tests in European countries by type of screening offer: Results from the European Health Interview Survey. Cancers (Basel) 2020; 12: 1409
    CrossrefPubMedSuche in Google Scholar
  • 8 Singal AG, Gupta S, Skinner CS. et al. Effect of colonoscopy outreach vs fecal immunochemical test outreach on colorectal cancer screening completion: A randomized clinical trial. JAMA 2017; 318: 806-815
    CrossrefPubMedSuche in Google Scholar
  • 9 Kaminski MF, Thomas-Gibson S, Bugajski M. et al. Performance measures for lower gastrointestinal endoscopy: a European Society of Gastrointestinal Endoscopy (ESGE) Quality Improvement Initiative. Endoscopy 2017; 49: 378-397
    Thieme ConnectPubMedSuche in Google Scholar
  • 10 Bronzwaer MES, Depla A, van Lelyveld N. et al. Quality assurance of colonoscopy within the Dutch national colorectal cancer screening program. Gastrointest Endosc 2019; 89: 1-13
    CrossrefPubMedSuche in Google Scholar
  • 11 Frösch B, Antony K, Ivansits S. Übersicht nationaler Kolonkrebs-Screening-Programme. 2016. Gesundheit Österreich; Vienna:
    Suche in Google Scholar
  • 12 Caviglia GP, Cabianca L, Fagoonee S. et al. Colorectal cancer detection in an asymptomatic population: fecal immunochemical test for hemoglobin vs. fecal M2-type pyruvate kinase. Biochem Med (Zagreb) 2016; 26: 114-120
    CrossrefPubMedSuche in Google Scholar
  • 13 Leen R, Seng-Lee C, Holleran G. et al. Comparison of faecal M2-PK and FIT in a population-based bowel cancer screening cohort. Eur J Gastroenterol Hepatol 2014; 26: 514-518
    CrossrefPubMedSuche in Google Scholar
  • 14 Lieberman DA, Rex DK, Winawer SJ. et al. Guidelines for colonoscopy surveillance after screening and polypectomy: A consensus update by the US Multi-Society Task Force on Colorectal Cancer. Gastroenterology 2012; 143: 844-857
    CrossrefPubMedSuche in Google Scholar
  • 15 Kaminski MF, Regula J, Kraszewska E. et al. Quality indicators for colonoscopy and the risk of interval cancer. N Engl J Med 2010; 362: 1795-1803
    CrossrefPubMedSuche in Google Scholar
  • 16 Kligman E, Li W, Eckert GJ. et al. Adenoma detection rate in asymptomatic patients with positive fecal immunochemical tests. Dig Dis Sci 2018; 63: 1167-1172
    CrossrefPubMedSuche in Google Scholar
  • 17 Zorzi M, Antonelli G, Barbiellini Amidei C. et al. Adenoma detection rate and colorectal cancer risk in fecal immunochemical test screening programs: an observational cohort study. Ann Intern Med 2023; 176: 303-310
    CrossrefPubMedSuche in Google Scholar
  • 18 Corley DA, Jensen CD, Chubak J. et al. Evaluating different approaches for calculating adenoma detection rate: Is screening colonoscopy the gold standard?. Gastroenterology 2023; 165: 784-787 e4
    CrossrefPubMedSuche in Google Scholar
  • 19 Mohan BP, Khan SR, Daugherty E. et al. Pooled rates of adenoma detection by colonoscopy in asymptomatic average-risk individuals with positive fecal immunochemical test: a systematic review and meta-analysis. Gastrointest Endosc 2022; 96: 208-222 e14
    CrossrefPubMedSuche in Google Scholar
  • 20 Navarro M, Nicolas A, Ferrandez A. et al. Colorectal cancer population screening programs worldwide in 2016: An update. World J Gastroenterol 2017; 23: 3632-3642
    CrossrefPubMedSuche in Google Scholar
  • 21 Vanaclocha-Espi M, Ibanez J, Molina-Barcelo A. et al. Optimal cut-off value for detecting colorectal cancer with fecal immunochemical tests according to age and sex. PLoS One 2021; 16: e0254021
    CrossrefPubMedSuche in Google Scholar
  • 22 Penz D, Waldmann E, Hackl M. et al. Colorectal cancer and precursor lesion prevalence in adults younger than 50 years without symptoms. JAMA Netw Open 2023; 6: e2334757
    CrossrefPubMedSuche in Google Scholar
  • 23 van den Berg DMN, Nascimento de Lima P, Knudsen AB. et al. NordICC Trial results in line with expected colorectal cancer mortality reduction after colonoscopy: A modeling study. Gastroenterology 2023; 165: 1077-1079 e2
    CrossrefPubMedSuche in Google Scholar
  • 24 Cardoso R, Guo F, Heisser T. et al. Colorectal cancer incidence, mortality, and stage distribution in European countries in the colorectal cancer screening era: an international population-based study. Lancet Oncol 2021; 22: 1002-1013
    CrossrefPubMedSuche in Google Scholar
  • 25 Wilhelmsen M, Njor SH, Roikjaer O. et al. Impact of screening on short-term mortality and morbidity following treatment for colorectal cancer. Scand J Surg 2021; 110: 465-471
    CrossrefPubMedSuche in Google Scholar
  • 26 Troelsen FS, Sorensen HT, Pedersen L. et al. Root-cause analysis of 762 Danish post-colonoscopy colorectal cancer patients. Clin Gastroenterol Hepatol 2023; 21: 3160-3169.e5
    CrossrefPubMedSuche in Google Scholar
  • 27 Zessner-Spitzenberg J, Waldmann E, Jiricka L. et al. Comparison of adenoma detection rate and proximal serrated polyp detection rate and their effect on post-colonoscopy colorectal cancer mortality in screening patients. Endoscopy 2023; 55: 434-441
    Thieme ConnectPubMedSuche in Google Scholar
  • 28 Rutter MD, Senore C, Bisschops R. et al. The European Society of Gastrointestinal Endoscopy Quality Improvement Initiative: developing performance measures. Endoscopy 2016; 48: 81-89
    Thieme ConnectPubMedSuche in Google Scholar
  • 29 Lee TJ, Siau K, Esmaily S. et al. Development of a national automated endoscopy database: The United Kingdom National Endoscopy Database (NED). United European Gastroenterol J 2019; 7: 798-806
    CrossrefPubMedSuche in Google Scholar
  • 30 Mon HM, Robb KA, Demou E. Effectiveness of workplace cancer screening interventions: a systematic review. BMC Cancer 2024; 24: 999
    CrossrefPubMedSuche in Google Scholar
  • 31 Gautom P, Rosales AG, Petrik AF. et al. Evaluating the reach of a patient navigation program for follow-up colonoscopy in a large federally qualified health center. Cancer Prev Res 2024; 17: 325-333
    CrossrefPubMedSuche in Google Scholar
  • 32 Basu P, Ponti A, Anttila A. et al. Status of implementation and organization of cancer screening in The European Union Member States-Summary results from the second European screening report. Int J Cancer 2018; 142: 44-56
    CrossrefPubMedSuche in Google Scholar
  • 33 Litwin O, Sontrop JM, McArthur E. et al. Uptake of colorectal cancer screening by physicians is associated with greater uptake by their patients. Gastroenterology 2020; 158: 905-914
    CrossrefPubMedSuche in Google Scholar
  • 34 Hannon PA, Vu T Ogdon S. et al. Implementation and process evaluation of a workplace colorectal cancer screening program in eastern Washington. Health Promot Pract 2013; 14: 220-227
    CrossrefPubMedSuche in Google Scholar
  • 35 Walsh JM, Potter MB, Arora M. et al. A workplace colorectal cancer screening program in firefighters: lessons learned. Occup Med (Lond) 2014; 64: 255-258
    CrossrefPubMedSuche in Google Scholar